MDRX · As filed with the SEC
Veradigm cash flow statement, by fiscal year
The statement as Veradigm presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2024 Year ended Dec 31, 2024 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income (loss) | (291,579,000) | (86,462,000) | 134,438,000 | 700,407,000 |
| Less: Income (loss) from discontinued operations | 0 | (66,418,000) | 463,000 | 833,026,000 |
| Income (loss) from continuing operations | — | — | 133,975,000 | (132,619,000) |
| Income (loss) from continuing operations, net of tax | (291,579,000) | (20,044,000) | — | — |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | 45,776,000 | 115,921,000 | 176,137,000 | 192,269,000 |
| Operating right-of-use asset amortization | — | — | — | 20,720,000 |
| Non-cash lease expense, net | — | — | (3,859,000) | — |
| Noncash rent expense | 3,477,000 | — | — | — |
| Amortization of debt discounts, premiums and issuance costs | 12,298,000 | — | — | — |
| Stock-based compensation expense | 24,523,000 | 25,117,000 | 35,169,000 | 34,036,000 |
| Deferred taxes | 67,262,000 | (55,877,000) | (2,099,000) | (3,275,000) |
| Asset impairment charges | — | — | — | 74,969,000 |
| Goodwill impairment charge | — | — | — | 0 |
| Impairment of long-term investments | — | — | — | 1,575,000 |
| Provision for credit losses | 15,333,000 | — | — | — |
| Loss on debt extinguishment | 17,632,000 | — | — | — |
| Impairment of goodwill and other assets and long-term investments | 108,891,000 | 15,124,000 | 11,772,000 | — |
| Equity in net loss of unconsolidated investments | 7,175,000 | 1,143,000 | (1,757,000) | (17,194,000) |
| (Gain) loss on sale of businesses, net | — | 0 | (8,370,000) | 0 |
| Other (income) expense, net | (2,634,000) | 33,865,000 | (69,141,000) | (5,900,000) |
| Changes in operating assets and liabilities (net of businesses acquired): | ||||
| Accounts receivable and contract assets, net | (13,526,000) | 9,549,000 | (5,002,000) | 35,163,000 |
| Prepaid expenses and other assets | (23,527,000) | (776,000) | 17,794,000 | (34,418,000) |
| Accounts payable | 8,891,000 | 27,870,000 | (18,729,000) | (66,987,000) |
| Accrued expenses | 5,946,000 | (26,507,000) | 21,971,000 | (3,064,000) |
| Accrued compensation and benefits | 2,481,000 | 5,590,000 | (26,034,000) | 49,492,000 |
| Deferred revenue | 8,062,000 | 2,087,000 | (13,692,000) | 28,667,000 |
| Other liabilities | (11,986,000) | 10,246,000 | 205,000 | 5,334,000 |
| Operating leases | — | — | — | (19,266,000) |
| Right-of-use assets - operating leases | (4,520,000) | (4,489,000) | — | — |
| Accrued DOJ settlement | — | 0 | 0 | (147,169,000) |
| Net cash provided by (used in) operating activities - continuing operations | (20,025,000) | 138,819,000 | 248,340,000 | 12,333,000 |
| Net cash provided by (used in) operating activities - discontinued operations | 0 | (23,257,000) | (323,768,000) | (119,048,000) |
| Net cash provided by (used in) operating activities | (20,025,000) | 115,562,000 | (75,428,000) | (106,715,000) |
| Cash flows from investing activities: | ||||
| Capital expenditures | (1,552,000) | (2,062,000) | (5,295,000) | (17,025,000) |
| Capitalized software | (28,630,000) | (30,204,000) | (73,265,000) | (87,993,000) |
| Cash paid for business acquisitions, net of cash acquired | (107,259,000) | (31,988,000) | 0 | 0 |
| Cash received from sale of businesses, net of cash divested | — | — | — | 1,710,000,000 |
| Sale of businesses, net of cash divested | 0 | 672,471,000 | 68,806,000 | — |
| Sale of investment | 25,864,000 | — | — | — |
| Purchases of equity securities, other investments and related intangible assets, net | (14,094,000) | (9,933,000) | (2,421,000) | (7,097,000) |
| Sale of other investments | — | — | — | 24,967,000 |
| Other proceeds from investing activities | — | — | 0 | 0 |
| Net cash provided by (used in) investing activities - continuing operations | (125,671,000) | 598,284,000 | (12,175,000) | 1,622,852,000 |
| Net cash provided by (used in) investing activities - discontinued operations | 0 | (13,138,000) | 0 | (7,664,000) |
| Net cash provided by (used in) investing activities | (125,671,000) | 585,146,000 | (12,175,000) | 1,615,188,000 |
| Cash flows from financing activities: | ||||
| Proceeds from sale or issuance of common stock | — | — | — | 0 |
| Taxes paid related to net share settlement of equity awards | (3,187,000) | (32,129,000) | (14,023,000) | (6,033,000) |
| Proceeds from issuance of 0.875% Convertible Senior Notes | — | — | 0 | 0 |
| Payments for issuance costs on 0.875% Convertible Senior Notes | — | — | 0 | (758,000) |
| Repayment of Convertible Senior Notes | — | 0 | 0 | (352,361,000) |
| Credit facility payments | — | — | (75,000,000) | (1,315,000,000) |
| Payments of debt amendment fees | (1,984,000) | — | — | — |
| Payments for capped call transaction | (279,000) | — | 0 | 0 |
| Credit facility payments | 0 | (200,000,000) | — | — |
| Credit facility borrowings, net of issuance costs | 0 | 21,643,000 | 250,000,000 | 903,625,000 |
| Unused commitment fees on credit facility | (1,202,000) | — | — | — |
| Repurchase of common stock | 0 | (234,425,000) | (417,443,000) | (134,863,000) |
| Accelerated Share Repurchase Program | — | — | — | (200,000,000) |
| Payment of acquisition and other financing obligations | — | 0 | (2,400,000) | (4,369,000) |
| Purchases of subsidiary shares owned by non-controlling interest | — | — | 0 | 0 |
| Net cash provided by (used in) financing activities - continuing operations | (6,652,000) | (444,911,000) | — | (1,109,759,000) |
| Net cash provided by (used in) financing activities - discontinued operations | — | — | — | 0 |
| Net cash provided by (used in) financing activities | (6,652,000) | (444,911,000) | (258,866,000) | (1,109,759,000) |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 452,000 | (476,000) | 1,212,000 |
| Net increase (decrease) in cash and cash equivalents | (152,348,000) | 256,249,000 | (346,945,000) | 399,926,000 |
| Cash, cash equivalents and restricted cash, beginning of period | 446,601,000 | 191,651,000 | 537,465,000 | 137,539,000 |
| Cash, cash equivalents and restricted cash, end of period | 294,253,000 | 447,900,000 | 190,520,000 | 537,465,000 |
| Cash paid during the period for: | ||||
| Interest | 2,169,000 | — | — | — |
| Income taxes, net of refunds | 14,325,000 | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.